Abstract
Aims: The aim of this study was to evaluate the presence of yeasts in dental chair unit waterlines (DCUWLs) and to test their ability to form biofilms. Materials and methods: Eighteen dental waterlines were analysed by culture in liquid Sabouraud in order to allow the quantification and the purification of isolated yeasts from their internal surfaces. All isolates were identified by standard laboratory procedures, including CHROMagar Candida medium for orientation, commercial yeast identification system Api Candida, MALDI-TOF MS and DNA sequencing. To evaluate their kinetics of antifungal susceptibility during different phases of biofilm formation, these yeasts were subjected to three antifungal agents. Results: From the 18 DCUWLs studied, 10 were altered (55.56%). Eleven strains of Candida sp. [Candida albicans (2), Candida guilliermondii (5) and Candida glabrata (4)] and two species of non-Candida; Rhodotorula spp. (1) and Trichosporon spp. (2) were identified. The majority of yeasts in planktonic form were susceptible to amphotericin B, caspofungin and voriconazole, except C. albicans was resistant to voriconazole. In the biofilm form, caspofungin was the most effective antifungal agent for all isolated strains. For the other antifungal agents, sessile cells were resistant. Conclusion: Several types of yeasts were identified; the most frequently isolated genus was Candida. The majority of these yeasts had the ability to form biofilms and resisted antifungal agents used in this study
Key words: Dental public health, biofilm, antimicrobial resistance, molecular genetics, mycology
Introduction
Dental practice involves invasive surgical procedures in a naturally septic environment1., 2.. In a dental clinic, care is delivered in a dental unit (chair).
Dental chair units consist of a network of interconnected narrow-bore tubes called dental chair unit waterlines (DCUWLs). These DCUWLs constitute an ideal growth medium for microorganisms due to many factors, including: ambient temperatures, diameter of dental waterlines and stagnating water in these canalisations3.
However, once inside the DCUWLs, microorganisms settle on the internal face and trigger a series of events leading to: colonisation, formation of microscopic colonies and, eventually, to biofilm4.
In addition, few documented reports have evaluated the presence of yeasts in DCUWLs. Most scientific studies published in this area focus on bacterial contamination5., 6.. In this work, we were interested in: (i) the research on the presence of yeasts inside DCUWLs; (ii) the identification of isolated yeasts by conventional and molecular techniques; (iii) the study of their susceptibility to three antifungal agents and their ability to form biofilms; and (iv) the study of biofilms’ kinetics of susceptibility during different phases of development.
Materials and methods
Samples of DCUWLs (18) were taken from the dental clinic (13) and stomatology unit (5) at the university hospital of Tlemcen (Algeria). After disinfecting the external surface with alcohol, these samples were cut using a sterile scalpel. The parts collected from the DCUWLs were taken at random positions along the line. A sterile swab was inserted in the aperture of the samples and immersed in sterile Sabouraud liquid.
Strain identification
CHROMagar Candida medium (BBL-CHROMagar Candida, Becton Dickinson) was used for isolation and rapid purification of yeasts. Api Candida and MALDI-TOF MS were used to identify the isolated strains. For MALDI-TOF MS identification, the procedure recommended by the manufacturer (Bruker Daltonics GmbH, Germany) was followed.
DNA sequence-based identification of clinical strains
The sequencing of fungal ribosomal DNA was based on the amplification of internal transcribed spacer regions ITS1–ITS2.
Primers used for the amplification of ITS1-5.8s-ITS2 region were ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-TCCTCCGCTTATTGATATGC-3′)7.
The obtained sequences were subjected to a sequence homology search using the program of alignment Blast (Basic Alignment Search Tool).
Biofilm growth kinetics on the surface of microtitre plate wells
All yeasts recovered from the DCUWLs were selected to study their ability to form biofilms on the surfaces of microtitre plates. The biofilm-forming species were retained to study their capacity to form biofilms against antifungal agents over time interval of 4, 24, 48 and 72 hours4.
Antifungal susceptibility
Planktonic cells [minimal inhibitory concentrations (MICs)]
The determination of MICs of planktonic cells was performed by the Clinical Laboratory Standards Institute (CLSI) M27-A3 broth microdilution method with a reading of endpoints at 24 hours (caspofungin) and 48 hours (amphotericin B and voriconazole)8.
Sessile cells [sessile minimal inhibitory concentrations (SMIC)]
The action of amphotericin B, voriconazole and caspofungin was tested on formed biofilm. The ability of Candida sp. strains to form biofilms was considered positive if the SMICs were above the MIC. MICs and SMICs were determined using the XTT-reduction assay9.
XTT-reduction assay
For the quantification of living cells, the XTT-reduction assay was used. The principle of XTT-reduction assay was to measure metabolic activities of cells within the biofilm9.
Results
A total number of 14 yeasts were isolated and identified.
In terms of frequency, among the 11 isolates of Candida sp., Candida albicans accounted for 14.3% (n = 2) of the isolates, while species not C. albicans accounted for 64.3% (n = 9) of isolates, mainly represented by Candida guilliermondii 35.7% (n = 5) and Candida glabrata 28.6% (n = 4).
Other species not members of the Candida genus (21.4%), such as Rhodotorula spp. 7.1% (n = 1) and Trichosporon spp. 14.3% (n = 2) were also isolated.
The conventional identification of yeasts was based on the use of morphological (CHROMagar Candida medium) and biochemical tests (API Candida, bioMérieux).
MALDI-TOF MS was used to confirm or to correct the identification of Candida sp. previously identified by Api Candida. The log score (LS) of each strain was used for the identification.
MALDI-TOF MS technique allowed the confirmation of the identification of two strains; C. guilliermondii/Candida famata to C. guilliermondii and to correct Candida parapsilosis to C. glabrata.
The results of our study showed that all the values of best scores LS were above 2. The strains presenting scores < 2 were subjected to further tests.
The results of the identification at the species level by API Candida, CHROMagar Candida and MALDI-TOF MS are presented in Table 1.
Table 1.
Identification by API Candida, CHROMagar Candida and the values of the best-score and the second-score (LS) of identification by MALDI-TOF MS
Api Candida | CHROMagar Candida | MS-based identification | ||
---|---|---|---|---|
Best score LS | Species | Second score LS | ||
C. albicans | C. albicans | 2.373 | C. albicans | 2.337 |
C. albicans | C. albicans | 2.37 | C. albicans | 2.369 |
C. guilliermondii/C. famata | C. guilliermondii | 2.238 | C. guilliermondii | 2.017 |
C. guilliermondii/C. famata | C. guilliermondii | 2.103 | C. guilliermondii | 1.875 |
C. guilliermondii/C. famata | C. guilliermondii | 2.195 | C. guilliermondii | 1.981 |
C. guilliermondii/C. famata | C. guilliermondii | 2.231 | C. guilliermondii | 2.066 |
C. guilliermondii/C. famata | C. tropicalis | 2.094 | C. guilliermondii | 1.916 |
C. glabrata/C. famata/Geotrichum spp | C. glabrata | 2.543 | C. glabrata | 2.515 |
C. glabrata/C. famata/Geotrichum spp | C. glabrata | 2.528 | C. glabrata | 2.495 |
C. parapsilosis | C. glabrata | 2.565 | C. glabrata | 2.496 |
C. glabrata | C. glabrata | 2.577 | C. glabrata | 2.49 |
LS, log score.
Comparing those results, there was a discrepancy in the identification between the techniques; 63.6% of strains had a correct identification by the three techniques. In effect, all isolates have been correctly identified using the MALDI-TOF MS.
DNA sequencing
Only yeasts with discordant identification results were selected for this technique.
The obtained sequences were then compared using an alignment tool sequences fungi (Table 2).
Table 2.
Characteristics of yeast included in the reference DNA sequence database
DNA sequence-based identification | |||
---|---|---|---|
Species | n | Strains no. | BLAST ref. with ≥ 99% identity |
C. guilliermondii | 2 | 5 | KC119207.1 |
17 | JQ678690.1 | ||
C. glabrata | 3 | 13 | CR380958.2 |
8 | CR380958.2 | ||
T3B2G | CR380958.2 |
The sequencing of inter-genic regions ITS1 and ITS2 confirmed the identification of strains by MALDI-TOF MS.
The final result of identification of isolated yeasts from DCUWLs revealed the following: two (2) strains of C. albicans; five (5) strains of C. guilliermondii; four (4) strains of C. glabrata; one strain (1) of Rhodotorula spp.; and two (2) strains of Trichosporon spp.
Determination of MIC
The MIC of caspofungin was calculated after 24 hours, whereas the MIC of voriconazole and the MIC of amphotericin B were calculated after 48 hours of incubation. The same conditions were applied to determine the SMIC.
According to the Clinical Laboratory Standard Institute (CLSI; M27-S3)10, the yeast was considered susceptible to amphotericin B if the MIC was ≤ 1 μg/mL and was susceptible to casposfungin and voriconazole if the MIC was ≤ 2 μg/mL.
The results indicated that all isolated yeasts were susceptible to amphotericin B (MIC ≤ 1 μg/mL), caspofungin (MIC ≤ 0.5 μg/mL) and voriconazole (MIC ≤ 1 μg/mL), with the exception of two C. albicans strains that were resistant to voriconazole (MIC = 16 μg/mL).
Determination of SMIC
Table 3 reported the results of SMICs of amphotericin B, caspofungin and voriconazole against isolated and reference strains.
Table 3.
In vitro antifungal susceptibility of isolated yeasts recovered from 18 DCUWLs under planktonic (MIC) and biofilm (SMIC) growing conditions with amphotericin B, caspofungin and voriconazole (μg/mL)
Isolates | Amphotericin B | Caspofungin | Voriconazole | ||||||
---|---|---|---|---|---|---|---|---|---|
Planktonic | Sessile | Planktonic | Sessile | Planktonic | Sessile | ||||
MIC | MIC50 | MIC80 | MIC50 | MIC50 | MIC80 | MIC50 | MIC50 | MIC80 | |
C. albicans 1 | 0.25 | 2 | 4 | 0.0313 | 0.25 | 1 | 16 | 32 | ˃ 32 |
C. albicans 2 | 0.5 | 4 | 8 | 0.0313 | 0.5 | 2 | 16 | ˃ 32 | ˃ 32 |
C. glabrata 1 | 0.125 | 0.5 | 1 | 0.0313 | 0.0625 | 0.125 | 0.5 | 1 | 1 |
C. glabrata 2 | 0.125 | 0.5 | 2 | 0.125 | 0.25 | 0.5 | 0.25 | 2 | 4 |
C. glabrata 3 | 0.125 | 0.5 | 2 | 0.125 | 0.125 | 0. 25 | 0.25 | 1 | 2 |
C. glabrata 4 | 0.25 | 1 | 2 | 0.0625 | 0.125 | 0.5 | 0.5 | 2 | 4 |
Rhodotorula sp. | 1 | 2 | 4 | 0.0625 | 0.25 | 0.5 | 0.0625 | 2 | 4 |
C. albicans ATCC 10231 | 0.25–0.5 | 2 | 4–8 | 0.0625 | 0.5 | 1 | 1 | 1 | 2 |
MIC, minimal inhibitory concentration.
Caspofungin was more effective against all isolated species (0.0625 ≤ SMIC50 ≤ 2 μg/mL), with SMIC50 ≤ 2 μg/mL for C. guilliermondii and SMIC50 ≤ 0.5 μg/mL for C. albicans, C. glabrata, Rhodotorula spp. and C. albicans ATCC 10231.
Furthermore, for amphotericin B, a single strain of C. glabrata was susceptible (MIC ≤ 1 μg/mL) under planktonic and sessile forms. For the other C. glabrata and isolated strains, all were resistant (SMIC80 > 1 μg/mL).
The results indicated that biofilms formed were, intrinsically, resistant to amphotericin B as indicated by SMIC80. Also, activity against biofilms was increased up to 4–512 times compared with that against planktonic cells.
However, SMIC50 of voriconazole showed that 50% of C. glabrata, 40% of C. guilliermondii and Rhodotorula spp. were susceptible, at a dependent dose, to voriconazole (SMIC = 2 μg/mL). For C. albicans all strains were resistant to this antifungal agent with SMIC = 32 μg/mL.
For C. albicans ATCC 10231, the obtained MICs of amphotericin B, caspofungin and voriconazole were 4, 0.5 and 1 μg/mL, respectively. These MICs were superior to those obtained by CLSI method, except for voriconazole, where the SMIC was the same as that of planktonic cells.
Determination of SMICs during different phases of formation of biofilms
The SMICs were measured according to the protocol of Pierce et al.9 after 4, 24, 48 and 72 hours of incubation at 37 °C.
The result of kinetic susceptibility of selected sessile cells in the presence of amphotericin B, caspofungin and voriconazole are presented in Figure 1.
Figure 1.
Kinetics of biofilm formation of isolated and reference strains Candida sp. and Candida albicans ATCC 10231 against (a) amphotericin B, (b) voriconazole and (c) caspofungine during the different phases of biofilm development.
The XTT reduction test was used to assess the metabolic activities of biofilms and deduct SMICs during different phases of their development.
Four phases of biofilm development were reported: (i) the initial adherence phase (adhesion); (ii) the growth phase; (iii) the maturation phase; and (iv) the final phase.
During adherence and growth phases, we observed that the SMICs were nearest to the values of MIC given previously.
During the maturation phase (24–48 hours), resistance to antifungal agents was clearly increased: from 2 to 16 μg/mL for amphotericin B, from 0.5 to 4 μg/mL for caspofungin, and from 2 to ˃ 32 μg/mL for voriconazole.
Candida glabrata and C. albicans showed significant susceptibility to caspofugin under the different environmental conditions (planktonic or sessile), but C. guilliermondii was less susceptible.
In the last phase of biofilm formation (72 hours), the yeasts were extremely resistant. All strains react in the same way, with increased resistance, with different SMIC (4–16 μg/mL for amphotericin B, 1–4 μg/mL for caspofungin, and 2 to ˃ 32 μg/mL for voriconazole). Moreover, sessile cells were more resistant compared with planktonic cells when the biofilm reached maturity.
Discussion
Yeast are part of the contamination of DCUWLs. From 14 isolated yeast strains, 11 were identified as Candida sp. Indeed, the majority of Candida sp. strains were capable of forming biofilms with a decrease in their susceptibility to the antifungal agents tested.
The presence of Candida sp. and non-Candida sp. in water of dental units was reported by several authors11., 12., 13.. The results of predominant isolated strains from DCUWLs obtained from this study corroborated those of Szymańska13 and Kadaifciler et al.14, which demonstrated that the most isolated yeasts were C. albicans, C. guilliermondii, C. famata, C. curvata and Geotrichum candidum.
Szymańska13 reported that there were several origins of fungal contamination of DCUWLs; dental unit feed water, return and re-aspiration of biological fluids as a result of the negative pressure produced when the equipment is turned off.
Other factors may also explain the presence of yeasts in DCUWLs, such as: stagnant water in the tubing (nights, weekends and holidays); the size and nature of tubing surfaces; as well as water temperature12. These factors promoted not only fungal proliferation, but also biofilm formation16.
The isolated yeasts were identified by MALDI TOF MS. According to Cassagne et al.7 and Normand et al.17, if the score (LS) was ≥ 2, the identification at the species level was verified.
The strains with a score ˂ 2 had undergone sequencing of their DNA. For this, C. guilliermondii/C. famata, with a score ˂ 2, the sequencing of the inter-genic regions ITS1 and ITS2 confirmed their identification as C. guilliermondii.
Desnos-Ollivier et al.18 and Savini et al.19 reported that ITS regions were good tools for biochemical differentiating of C. guilliermondii and C. famata species. This was confirmed in our study.
The results for the determination of MIC were corroborated with those of Seghir et al.20, which showed that all yeasts isolated at Tlemcen University Hospital were susceptible to amphotericin B and caspofungin.
Indeed, according to Ramage et al.21 and Pfaller et al.22, amphotericin B and caspofungin were the most effective antifungal agents with very few cases of resistance, and offer an interesting alternative in the management of invasive fungal infections in hospitals23.
The results were similar to those of Kovacicova et al.24 that showed that the MICs of amphotericin B against the sessile cells of Candida sp. were 30–2000 times higher than those for planktonic forms.
The resistance of these yeasts to amphotericin B were reported by several researchers24., 25.. Generally, the adhesion and biofilm production capacity depends on the specific characteristics of each isolate26., 27., 28..
The results of SMIC during the different phases of biofilm formation were in agreement with other studies29., 30., which showed that the exopolymeric matrix (extracellular), which prevented the penetration and the diffusion of the drug in the biofilm, were missed during the initial phase of biofilm development. This explained the low SMIC in the adhesion phase (4 hours). It was reported that the exopolymeric matrix did not influence the action of antifungal agent on yeasts. This fact suggested that the matrix was not the major determining fact in resistance31., 32..
In the maturation phase, resistance to antifungal agents increased; the biofilm completes its formation, its architecture became more complex (24–48 hours)25., 33.. The increase of SMIC from one stage to another explained the amplification of resistance of sessile cells against antifungal agents.
These results are in agreement with those reported in the literature33., 34.. The biofilms formed by C. albicans, C. glabrata and C. guilliermondii showed more resistance to antifungal agents than their counterparts (planktonic cells)35., 36.. Amphotericin B had an inhibiting effect on these sessile cells with higher concentrations of the drug37.
The azoles (including voriconazole) showed no activity against biofilms formed by Candida sp38., 39.. In our study, the majority of C. glabrata were less susceptible to voriconazole. The prolongation of the incubation time caused the increase of MIC. This fact was confirmed in other studies36., 40..
It was demonstrated that biofilm’s fluconazole resistance could be explained by the expression of the efflux pumps in the first phase of biofilm formation or they could be due to the attachment of azole to glucan in the exopolymeric matrix41., 42., 43., 44..
In addition, factors responsible for the resistance of fungal biofilms included: limited penetration of antifungal agents due to the extracellular matrix; physiological status of sessile cells (a slow growth rate); differential expression of genes (expression of efflux pumps); disturbances of sterols; high cell density in the biofilm; and the presence of persistent cells27., 32..
Conclusion
This study showed that DCUWLs were contaminated with yeasts, the majority of which had the capacity to form biofilms. Mycological contamination of DCUWLs remains a serious problem. Effective cleaning and disinfection practices should be applied to reduce or eliminate pathogenic microorganisms. It is also necessary to check the maintenance protocols of dental equipment to improve the quality of the water, and to regularly check for contamination to minimise the risks of exposure to potentially pathogenic agents.
Acknowledgements
The authors thank Dr Stéphane Ranque and Pr Renaud Piarroux for having allowed them to perform a part of this work in their laboratory (Laboratoire de Parasitologie-Mycologie, APHM Timone, Marseille, France). This research was supported by Abou Bekr Belkaid University Tlemcen, Higher Education and Scientific Research Ministry of Algeria.
Conflict of interest
None declared.
References
- 1.Richaud-Morel B, Boudot E, Arlin LR, et al. Prévention des infections associées aux soins en chirurgie dentaire dans les établissements de santé. CCLIN Sud-Ouest. 2011;6:1–12. [Google Scholar]
- 2.Kumar S, Atray D, Paiwal D, et al. Dental unit waterlines: source of contamination and cross-infection. J Hosp Infect. 2010;74:99–111. doi: 10.1016/j.jhin.2009.03.027. [DOI] [PubMed] [Google Scholar]
- 3.Barbeau J. Waterborne biofilms and dentistry: the changing face of infection control. J Can Dent Assoc. 2000;66:539–541. [PubMed] [Google Scholar]
- 4.Mazari W, Boucherit-Otmani Z, Boucherit K. In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dental unit waterlines, under different growth phases. J Med Mycol. 2015;25:57–62. doi: 10.1016/j.mycmed.2014.10.027. [DOI] [PubMed] [Google Scholar]
- 5.Coleman DC, O’Donnell MJ, Shore AC, et al. Biofilm problems in dental unit water systems and its practical control. J Appl Microbiol. 2009;106:1424–1437. doi: 10.1111/j.1365-2672.2008.04100.x. [DOI] [PubMed] [Google Scholar]
- 6.Göksay D, Cotuk A, Zeybek Z. Microbial contamination of dental unit waterlines in Istanbul, Turkey. Environ Monit Assess. 2008;147:265–269. doi: 10.1007/s10661-007-0118-0. [DOI] [PubMed] [Google Scholar]
- 7.Cassagne C, Cella A, Suchon P, et al. Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory. Med Mycol. 2013;51:371–377. doi: 10.3109/13693786.2012.720720. [DOI] [PubMed] [Google Scholar]
- 8.Clinical and Laboratory Standards Institute, CLSI . 3rd edn. Clinical and Laboratory Standards Institute, CLSI; Wayne, PA: 2008. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard. M27-A3. ISBN 1-56238-666-2. [Google Scholar]
- 9.Pierce CG, Uppuluri P, Tristan AR, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3:1494–1500. doi: 10.1038/nport.2008.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Clinical and Laboratory Standards Institute, CLSI . Clinical and Laboratory Standards Institute, CLSI; Wayne, PA: 2008. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Informational Supplement. M27-S3. [Google Scholar]
- 11.Ghannoum MA, Jurevic RJ, Mukherjee PK, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6:e1000713. doi: 10.1371/journal.ppat.1000713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Barbot V, Robert A, Rodier MH, et al. Update on infectious risks associated with dental unit waterlines. FEMS Immunol Med Microbiol. 2012;65:196–204. doi: 10.1111/j.1574-695X.2012.00971.x. [DOI] [PubMed] [Google Scholar]
- 13.Szymanska J. Evaluation of mycological contamination of dental unit waterlines. Ann Agric Environ Med. 2005;12:153–155. [PubMed] [Google Scholar]
- 14.Kadaifciler DG, Ökten S, Sen B. Mycological contamination in dental unit waterlines in Istanbul, Turkey. Braz J Microbiol. 2013;44:977–981. doi: 10.1590/s1517-83822013000300049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kadaifciler DG, Ökten S, Sen B, et al. Waterline biofilm and the dental treatment facility: a review. Gen Dent. 2002;50:190–195. [PubMed] [Google Scholar]
- 16.Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–193. doi: 10.1128/CMR.15.2.167-193.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Normand AC, Cassagne C, Ranque S, et al. Assessment of various parameters to improve MALDI-TOF MS reference spectra libraries constructed for the routine identification of filamentous fungi. BMC Microbiol. 2013;13:76. doi: 10.1186/1471-2180-13-76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Desnos-Ollivier M, Ragon M, Raoux VRD, et al. Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii) J Clin Microbiol. 2008;46:3237–3242. doi: 10.1128/JCM.01451-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Savini V, Catavitello C, Onofrillo D, et al. What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast. Mycoses. 2011;54:434–441. doi: 10.1111/j.1439-0507.2010.01960.x. [DOI] [PubMed] [Google Scholar]
- 20.Seghir A, Boucherit-Otmani Z, Belkherroubi-Sari L, et al. Catheterization and fungal infection risk in the University Hospital of Tlemcen: epidemiology and susceptibility to antifungals. J Med Mycol. 2014;24:179–184. doi: 10.1016/j.mycmed.2014.08.005. [DOI] [PubMed] [Google Scholar]
- 21.Ramage G, Jose A, Sherry L, et al. Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms. Antimicrob Agents Chemother. 2013;57:2369–2371. doi: 10.1128/AAC.02344-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Pfaller MA, Messer SA, Jones RN, et al. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010–2012) J Antibiot. 2015;68:556–561. doi: 10.1038/ja.2015.29. [DOI] [PubMed] [Google Scholar]
- 23.Constantin JM, Roszyk L, Guerin R, et al. Tolerance of caspofungin in intensive care unit: a prospective study. Ann Fr Anesth Reanim. 2008;27:819–824. doi: 10.1016/j.annfar.2008.06.013. [DOI] [PubMed] [Google Scholar]
- 24.Kovacicova G, Hanzen J, Pisarcikova M, et al. Nosocomial fungemia due to amphotericin B resistant Candida sp. in three pediatric patients after previous neurosurgery for brain tumors. J Infect Chemother. 2001;7:45–48. doi: 10.1007/s101560170033. [DOI] [PubMed] [Google Scholar]
- 25.Ramage G, Tomsett K, Wickes BL, et al. Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:53–59. doi: 10.1016/j.tripleo.2003.04.002. [DOI] [PubMed] [Google Scholar]
- 26.Silva S, Henriques M, Martins A, et al. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol. 2009;47:681–689. doi: 10.3109/13693780802549594. [DOI] [PubMed] [Google Scholar]
- 27.Valentin A, Canton E, Peman J, et al. Voriconazole inhibits biofilm formation in different species of the genus Candida. J Antimicrob Chemother. 2012;67:2418–2423. doi: 10.1093/jac/dks242. [DOI] [PubMed] [Google Scholar]
- 28.Alnuaimi AD, O’Brien-Simpson NM, Reynolds EC, et al. Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms. FEMS Yeast Res. 2013;13:689–699. doi: 10.1111/1567-1364.12068. [DOI] [PubMed] [Google Scholar]
- 29.Ramage G, Walle KV, Wickes BI, et al. Biofilm formation by Candida dubliniensis. J Clin Microbiol. 2001;39:3234–3240. doi: 10.1128/JCM.39.9.3234-3240.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ramage G, Vande Walle K, Wickes BL, et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001;45:2475–2479. doi: 10.1128/AAC.45.9.2475-2479.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbial. 2006;55:999–1008. doi: 10.1099/jmm.0.46569-0. [DOI] [PubMed] [Google Scholar]
- 32.Baillie GS, Douglas J. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agent. J Antimicrob Chemother. 2000;46:397–403. doi: 10.1093/jac/46.3.397. [DOI] [PubMed] [Google Scholar]
- 33.Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183:5385–5394. doi: 10.1128/JB.183.18.5385-5394.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Chandra J, Mukherjee PK, Ghannoum MA. In vitro growth and analysis of Candida biofilms. Nat Protoc. 2008;3:1909–1924. doi: 10.1038/nprot.2008.192. [DOI] [PubMed] [Google Scholar]
- 35.Beyda ND, Lewis RE, Garey KW. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother. 2012;46:1086–1096. doi: 10.1345/aph.1R020. [DOI] [PubMed] [Google Scholar]
- 36.Satish RK, Ramesh S. Novel intein-containing DNA specific primers for rapid identification of Candida glabrata using Real-Time PCR assays. J Mycol Med. 2014;24:337–340. doi: 10.1016/j.mycmed.2014.08.002. [DOI] [PubMed] [Google Scholar]
- 37.Douglas LJ. Medical importance of biofilms in Candida infections. Rev Iberoam Micol. 2002;19:139–143. [PubMed] [Google Scholar]
- 38.Melo AS, Bizerra FC, Freymüller E, et al. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol. 2011;49:253–262. doi: 10.3109/13693786.2010.530032. [DOI] [PubMed] [Google Scholar]
- 39.Uppuluri P, Srinivasan A, Ramasubramanian A, et al. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion. Antimicrob Agents Chemother. 2011;55:3591–3593. doi: 10.1128/AAC.01701-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Pfaller MA, Diekema DJ, Mendez M, et al. Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. J Clin Microbiol. 2006;44:3551–3556. doi: 10.1128/JCM.00865-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Mukherjee PK, Chandra J, Kuhn DM, et al. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun. 2003;71:4333–4340. doi: 10.1128/IAI.71.8.4333-4340.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Nett J, Lincoln L, Marchillo K, et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother. 2007;51:510–520. doi: 10.1128/AAC.01056-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Lazzell AL, Chaturvedi AK, Pierce CG, et al. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother. 2009;64:567–570. doi: 10.1093/jac/dkp242. [DOI] [PubMed] [Google Scholar]
- 44.Soustre J, Rodier MH, Imbert-Bouyer S, et al. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. J Antimicrob Chemother. 2004;53:522–525. doi: 10.1093/jac/dkh099. [DOI] [PubMed] [Google Scholar]